Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
fimepinostat (CUDC-907)
i
Other names:
CUDC-907, CUDC 907, CUDC907
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(8)
News
Trials
Company:
Curis
Drug class:
PI3K inhibitor, HDAC inhibitor
Related drugs:
‹
RTB101 (43)
PF-05212384 (31)
RG7440 (27)
chidamide (23)
GDC-0941 (22)
AN2025 (20)
GSK2126458 (17)
MEN1611 (16)
rigosertib (7)
LY294002 (7)
PF-04691502 (6)
RP6530 (6)
LY3023414 (5)
GDC-0980 (4)
A66 (3)
enzastaurin (3)
GDC-0084 (3)
PI-103 (2)
AEZS 136 (1)
AEZS-129 (1)
AZD8835 (1)
BAY 1082439 (1)
CB-006-3 (1)
DFN-529 (1)
KU-0060648 (1)
OP-11 (1)
SB02024 (1)
SRX3262 (1)
SAR245408 (1)
CBL0102 (1)
ASN003 (0)
AUM302 (0)
BGT226 (0)
DS-7423 (0)
ETP-47187 (0)
GDC-0349 (0)
GSK1059615 (0)
HEC68498 (0)
IBL-202 (0)
IBL-301 (0)
MTX-211 (0)
PIK-75 (0)
SAR260301 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
SL-901 (0)
SRX3177 (0)
TG 100-115 (0)
TOP216 (0)
VCD-597 (0)
VS-5584 (0)
WYE-125132 (0)
PQR309 (0)
NSC311152 (0)
inhibitors of the PI3K/AKT/mTOR pathway (0)
VT-11CR (0)
PX 866 (0)
SAR245409 (0)
vorinostat (19)
panobinostat (15)
romidepsin (9)
entinostat (9)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
SHP-141 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
RTB101 (43)
PF-05212384 (31)
RG7440 (27)
chidamide (23)
GDC-0941 (22)
AN2025 (20)
GSK2126458 (17)
MEN1611 (16)
rigosertib (7)
LY294002 (7)
PF-04691502 (6)
RP6530 (6)
LY3023414 (5)
GDC-0980 (4)
A66 (3)
enzastaurin (3)
GDC-0084 (3)
PI-103 (2)
AEZS 136 (1)
AEZS-129 (1)
AZD8835 (1)
BAY 1082439 (1)
CB-006-3 (1)
DFN-529 (1)
KU-0060648 (1)
OP-11 (1)
SB02024 (1)
SRX3262 (1)
SAR245408 (1)
CBL0102 (1)
ASN003 (0)
AUM302 (0)
BGT226 (0)
DS-7423 (0)
ETP-47187 (0)
GDC-0349 (0)
GSK1059615 (0)
HEC68498 (0)
IBL-202 (0)
IBL-301 (0)
MTX-211 (0)
PIK-75 (0)
SAR260301 (0)
SF1126 (0)
SF2523 (0)
SF2535 (0)
SL-901 (0)
SRX3177 (0)
TG 100-115 (0)
TOP216 (0)
VCD-597 (0)
VS-5584 (0)
WYE-125132 (0)
PQR309 (0)
NSC311152 (0)
inhibitors of the PI3K/AKT/mTOR pathway (0)
VT-11CR (0)
PX 866 (0)
SAR245409 (0)
vorinostat (19)
panobinostat (15)
romidepsin (9)
entinostat (9)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
SHP-141 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
MYC mutation
Diffuse Large B Cell Lymphoma
MYC mutation
Diffuse Large B Cell Lymphoma
CUDC-907
Sensitive: C3 – Early Trials
CUDC-907
Sensitive
:
C3
CUDC-907
Sensitive: C3 – Early Trials
CUDC-907
Sensitive
:
C3
BCR-ABL1 T315I
Chronic Myeloid Leukemia
BCR-ABL1 T315I
Chronic Myeloid Leukemia
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
ponatinib + CUDC-907
Sensitive: D – Preclinical
ponatinib + CUDC-907
Sensitive
:
D
ponatinib + CUDC-907
Sensitive: D – Preclinical
ponatinib + CUDC-907
Sensitive
:
D
BCR-ABL1 E255K
Chronic Myeloid Leukemia
BCR-ABL1 E255K
Chronic Myeloid Leukemia
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
BCR-ABL1 Y253H
Chronic Myeloid Leukemia
BCR-ABL1 Y253H
Chronic Myeloid Leukemia
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CRBN underexpression
Multiple Myeloma
CRBN underexpression
Multiple Myeloma
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
gilteritinib + CUDC-907
Sensitive: D – Preclinical
gilteritinib + CUDC-907
Sensitive
:
D
gilteritinib + CUDC-907
Sensitive: D – Preclinical
gilteritinib + CUDC-907
Sensitive
:
D
TP53 mutation
Medulloblastoma
TP53 mutation
Medulloblastoma
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
CUDC-907
Sensitive: D – Preclinical
CUDC-907
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login